drug development tool

(5) Drug development tool The term “drug development tool” includes— (A) a biomarker; (B) a clinical outcome assessment; and (C) any other method, material, or measure that the Secretary determines aids drug development and regulatory review for purposes of this section.


21 USC § 357(e)(5)

Scoping language

for purposes of this section
Is this correct? or